DESIGN OF A PHASE III, DOUBLE-BLIND, RANDOMIZED TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF ALLOGENEIC STEM CELLS (DARVADSTROCEL) FOR THE TREATMENT OF COMPLEX PERIANAL FISTULA(S) IN PATIENTS WITH CROHN'S DISEASE (ADMIRE-CD II TRIAL).

被引：0
|
作者：
Wexner, S.
Sandborn, W.
Panes, J.
Gilaberte, I.
Gulati, P.
Zhang, B.
Pfeifer, J.
Garcia-Olmo, D.
机构：
来源：
DISEASES OF THE COLON & RECTUM | 2020年 / 63卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P1158
引用
收藏
页码：E300 / E300
页数：1
相关论文
共 50 条
  • [41] Cx601, Expanded Allogeneic Adipose-Derived Mesenchymal Stem Cells (eASC), for Complex Perianal Fistulas in Crohn's Disease: Results From a Phase III Randomized Controlled Trial
    Panes, Julian
    Garcia-Olmo, Damian
    Van Assche, Gert
    Colombel, Jean-Frederic
    Reinisch, Walter
    Baumgart, Daniel C.
    Nachury, Maria
    Ferrante, Marc
    Kazemi-Shirazi, Lili
    Grimaud, Jean-charles
    de la Portilla, Fernando
    Goldin, Eran
    Leselbaum, Anne
    Tagarro, Ignacio
    Danese, Silvio
    GASTROENTEROLOGY, 2016, 150 (04) : S181 - S181
  • [42] Preliminary Report on the Efficacy of Allogeneic Bone Marrowderived Mesenchymal Stem Cells as a Disease-modifying Therapy for Idiopathic Parkinson's Disease: Phase IIa Double-blind, Randomized Controlled Trial
    Schiess, M.
    Suescun, J.
    Green, C.
    Tharp, E.
    Chandra, S.
    Adams, C.
    Shahnawaz, M.
    Rodarte, E.
    Thyne, V.
    Ellmore, T.
    MOVEMENT DISORDERS, 2023, 38 : S49 - S49
  • [43] PHASE III RANDOMIZED, DOUBLE-BLIND, CONTROLLED TRIAL TO COMPARE BIOSIMILAR INFLIXIMAB (CT-P13) WITH INNOVATOR INFLIXIMAB (INX) IN PATIENTS WITH ACTIVE CROHN'S DISEASE: EARLY EFFICACY AND SAFETY RESULTS
    Kim, Young Ho
    Ye, Byong Duk
    Pesegova, Marina
    Alexeeva, Olga
    Osipenko, Marina
    Lahat, Adi
    Dorofeyev, Andrey
    Salamon, Agnes
    Fishman, Sigal
    Levchenko, Olena
    Cheon, Jae Hee
    Scribano, Maria L.
    Mateescu, Radu-Bogdan
    Lee, Kang-Moon
    Eun, Chang Soo
    Lee, Sang Joon
    Lee, Sung Young
    GASTROENTEROLOGY, 2017, 152 (05) : S65 - S65
  • [44] Safety and efficacy of BI 695501 versus adalimumab reference product in patients with advanced Crohn's disease (VOLTAIRE-CD): a multicentre, randomised, double-blind, phase 3 trial
    Hanauer, Stephen
    Liedert, Bernd
    Balser, Sigrid
    Brockstedt, Ekkehard
    Moschetti, Viktoria
    Schreiber, Stefan
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021, 6 (10): : 816 - 825
  • [45] A phase III randomised controlled trial of Cx601, expanded allogeneic adipose-derived mesenchymal stem cells (eASC), for complex perianal fistulas in Crohn's disease
    Panes, J.
    Garcia-Olmo, D.
    Van Assche, G.
    Colombel, J. F.
    Reinisch, W.
    Baumgart, D. C.
    Nachury, M.
    Ferrante, M.
    Kazemi-Shirazi, L.
    Grimaud, J. C.
    de la Portilla, F.
    Goldin, E.
    Leselbaum, A.
    Diez, M. C.
    Danese, S.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S1 - S1
  • [46] A randomized, double-blind, placebo-controlled trial of lenalidomide in the treatment of moderately severe active Crohn's disease
    Mansfield, J. C.
    Parkes, M.
    Hawthorne, A. B.
    Forbes, A.
    Probert, C. S. J.
    Perowne, R. C.
    Cooper, A.
    Zeldis, J. B.
    Manning, D. C.
    Hawkey, C. J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2007, 26 (03) : 421 - 430
  • [47] Double-blind randomized controlled trial of glutamine-enriched polymeric diet in the treatment of active Crohn's disease
    Akobeng, AK
    Miller, V
    Stanton, J
    Elbadri, AM
    Thomas, AG
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2000, 30 (01): : 78 - 84
  • [48] Efficacy and Safety of Golimumab in Patients With Ankylosing Spondylitis Results of a Randomized, Double-Blind, Placebo-Controlled, Phase III Trial
    Inman, Robert D.
    Davis, John C., Jr.
    van der Heijde, Desiree
    Dickman, Laura
    Sieper, Joachim
    Kim, Sung Il
    Mack, Michael
    Han, John
    Visvanathan, Sudha
    Xu, Zhenhua
    Su, Benjamin
    Beutler, Anna
    Braun, Juergen
    ARTHRITIS AND RHEUMATISM, 2008, 58 (11): : 3402 - 3412
  • [49] Budesonide versus prednisolone for the treatment of active Crohn's disease in children: a randomized, double-blind, controlled, multicentre trial
    Escher, JC
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2004, 16 (01) : 47 - 54
  • [50] Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn's disease: a randomised, double-blind, placebo controlled trial (ADAFI)
    Dewint, Pieter
    Hansen, Bettina E.
    Verhey, Elke
    Oldenburg, Bas
    Hommes, Daniel W.
    Pierik, Marieke
    Ponsioen, Cyriel I. J.
    van Dullemen, Hendrik M.
    Russel, Maurice
    van Bodegraven, Ad A.
    van der Woude, C. Janneke
    GUT, 2014, 63 (02) : 292 - 299
12345